// App-Quantinova.ai

P422 : How achievable are the STRIDE-II treatment targets in real-world practise and do they affect outcome?

Researchers

Presenter

  • Routledge, E

Principal Investigators

  • Meade, S

  • Sharma, E

  • Zeki, S

  • Ray, S

  • Anderson, S

  • Sanderson, J

  • Mawdsley, J

  • Samaan, M

Medical Centers

  • Guy's and St Thomas' NHS Foundation Trust, Gastroenterology, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Gastroenterology (GU)

  • Genetic Disorder

Disease

  • Inflammatory bowel disease

  • Crohn's disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved